There are numerous reports of selective blockade of VEGFR2 activity in tumors resulting in reduced angiogenesis and tumor growth [19–23] suggesting that VEGFR1 activity is not required for VEGF-induced angiogenesis in pathological conditions. Here, FLT1 is linked to neoplasm.